Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
JNJ · against 1,370 other Healthcare companies
Ranked #854 of 1,371 · scores higher than 38% of peers · safety percentile 38
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)137 peers with a safety percentile of 30–39, including JNJ · Click a bar to see the companies
A mix: stronger beta, but weaker current ratio and debt / equity than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | JNJ | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 1,281 reported | 0.58× | 0.24× | 28% | 33% | |
| BetaLower is better · 1,333 reported | 0.23 | 0.53 | 74% | 33% | |
| Current ratioHigher is better · 1,338 reported | 1.09× | 2.59× | 13% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 510M USD | 100 | ||
| 1 | 4.6B USD | 100 | 54 | |
| 1 | 5.3B USD | 100 | 45 | |
| 4 | 252M USD | 100 | 52 | |
| 5 | 1.9B USD | 100 | 44 | |
| 850 | 34M USD | 38 | 24 | |
| 851 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 12.6B SAR (≈$3.4B) |
| 38 |
| 67 |
| 852 | 12.5B MXN (≈$677M) | 38 | 61 |
| 853 | 105M USD | 38 | 63 |
| 854 | 622.8B USD | 38 | 59 |
| 855 | 2.8B CNY (≈$386M) | 38 | 18 |
| 856 | 23.9B INR (≈$287M) | 38 | 62 |
| 857 | 3.7B CNY (≈$524M) | 38 | 54 |
| 858 | 15.6B CNY (≈$2.2B) | 37 | 36 |